​

McKesson (MCK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MCK Stock Forecast

McKesson (MCK) stock forecast, based on 13 Wall Street analysts, predicts a 12-month average price target of $626.71, with a high of $715.00 and a low of $535.00. This represents a 3.90% increase from the last price of $603.18.

$450 $510 $570 $630 $690 $750 High: $715 Avg: $626.71 Low: $535 Last Closed Price: $603.18

MCK Stock Rating

McKesson stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (84.62%), 2 Hold (15.38%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 13 0 2 11 Strong Sell Sell Hold Buy Strong Buy

MCK Forecast vs Benchmarks

TypeNameUpside
StockMcKesson3.90%
SectorHealthcare Stocks 25.20%
IndustryMedical Distribution Stocks-1.46%

Price Target Trends

1M3M12M
# Anlaysts-217
Avg Price Target-$701.50$594.76
Last Closing Price$603.18$603.18$603.18
Upside/Downside-16.30%-1.40%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 253104--17
Dec, 243104--17
Nov, 2441091125
Oct, 2461091127
Sep, 2461091127
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 19, 2024Rob DickersonJefferies$715.00$541.1532.13%18.54%
Nov 07, 2024Eric ColdwellRobert W. Baird$688.00$526.5430.66%14.06%
Sep 25, 2024George HillDeutsche Bank$579.00$479.1620.84%-4.01%
Sep 24, 2024Eric ColdwellRobert W. Baird$531.00$505.005.15%-11.97%
Sep 13, 2024Stephen BaxterWells Fargo$535.00$511.174.66%-11.30%
Sep 06, 2024Michael ChernyLeerink Partners$665.00$514.7529.19%10.25%
Sep 05, 2024Michael ChernyBank of America Securities$635.00$526.5020.61%5.28%
Aug 08, 2024Ann HynesMizuho Securities$570.00$617.51-7.69%-5.50%
Jul 09, 2024Eric ColdwellRobert W. Baird$694.00$589.5317.72%15.06%
Jun 24, 2024David ToungArgus Research$670.00$608.7210.07%11.08%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Nov 19, 2024JefferiesBuyBuyhold
Oct 01, 2024BarclaysPositivePositivehold
Sep 25, 2024Deutsche BankBuyBuyhold
Sep 24, 2024WedbushNeutraldowngrade
Sep 23, 2024JefferiesHoldHoldhold
Sep 13, 2024Wells FargoEqual-WeightEqual-Weighthold
Sep 06, 2024Leerink PartnersOutperformOutperformhold
Sep 05, 2024Bank of America SecuritiesBuyBuyhold
Aug 26, 2024Cowen & Co.BuyBuyhold
Jul 19, 2024CitigroupBuyBuyhold

Financial Forecast

EPS Forecast

$-30 $-12 $6 $24 $42 $60 Mar 20 Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 20Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$4.97$-27.02$7.31$25.23$22.54-----
Avg Forecast$14.79$17.23$23.89$25.96$27.61$32.69$36.82$41.28$46.94$53.78
High Forecast$14.36$16.74$23.20$25.16$27.47$32.40$35.56$35.30$45.51$52.14
Low Forecast$15.17$17.68$24.51$26.88$27.95$32.97$37.67$43.85$48.61$55.70
Surprise %-66.40%-256.82%-69.40%-2.81%-18.36%-----

Revenue Forecast

$200B $270B $340B $410B $480B $550B Mar 20 Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 20Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$231.05B$238.23B$263.97B$276.71B$308.95B-----
Avg Forecast$228.19B$240.05B$260.88B$275.91B$311.92B$360.18B$396.03B$424.30B$464.80B$517.85B
High Forecast$223.15B$234.74B$255.12B$269.43B$309.58B$357.80B$382.12B$423.39B$453.88B$505.68B
Low Forecast$232.78B$244.87B$266.13B$283.48B$312.88B$362.60B$412.08B$425.21B$477.55B$532.05B
Surprise %1.25%-0.76%1.18%0.29%-0.95%-----

Net Income Forecast

$-10B $-6B $-2B $2B $6B $10B Mar 20 Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 20Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$900.00M$-4.34B$1.11B$3.56B$3.00B-----
Avg Forecast$-965.70M$-3.74B$1.15B$3.48B$3.00B$4.38B$4.91B$5.31B$6.29B$7.21B
High Forecast$-1.38B$-5.20B$919.44M$3.37B$2.39B$4.34B$4.77B$4.73B$6.10B$6.99B
Low Forecast$-551.05M$-2.28B$1.39B$3.60B$3.60B$4.42B$5.05B$5.88B$6.52B$7.47B
Surprise %-193.20%15.99%-3.33%2.28%0.13%-----

MCK Forecast FAQ

Is McKesson stock a buy?

McKesson stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that McKesson is a favorable investment for most analysts.

What is McKesson's price target?

McKesson's price target, set by 13 Wall Street analysts, averages $626.71 over the next 12 months. The price target range spans from $535 at the low end to $715 at the high end, suggesting a potential 3.90% change from the previous close price of $603.18.

How does McKesson stock forecast compare to the average forecast of its sector, industry, and investment themes?

McKesson stock forecast shows a 3.90% upside, underperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the medical distribution stocks industry (-1.46%).

What is the breakdown of analyst ratings for McKesson over the past three months?

  • January 2025: 17.65% Strong Buy, 58.82% Buy, 23.53% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 17.65% Strong Buy, 58.82% Buy, 23.53% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 16.00% Strong Buy, 40.00% Buy, 36.00% Hold, 4.00% Sell, 4.00% Strong Sell.

What is McKesson’s EPS forecast?

McKesson's average annual EPS forecast for its fiscal year ending in March is 32.69 for 2025, a 45.03% increase from the reported $22.54 in 2024. The prediction for 2026 is $36.82, $41.28 for 2027, $46.94 for 2028, and $53.78 for 2029.

What is McKesson’s revenue forecast?

McKesson's average annual revenue forecast for its fiscal year ending in March is $360.18B for 2025, a 16.58% increase from the reported $308.95B in 2024. The forecast for 2026 is $396.03B, $424.3B for 2027, $464.8B for 2028, and $517.85B for 2029.

What is McKesson’s net income forecast?

For its fiscal year ending in March, McKesson's average annual net income forecast is $4.38B for 2025, reflecting an 45.98% increase from the reported $3B in 2024. The projection for 2026 is $4.91B, $5.31B for 2027, $6.29B for 2028, and $7.21B for 2029.